关注
Rosalba Leuci
Rosalba Leuci
在 uniba.it 的电子邮件经过验证
标题
引用次数
引用次数
年份
Natural compounds for the prevention and treatment of cardiovascular and neurodegenerative diseases
R Leuci, L Brunetti, V Poliseno, A Laghezza, F Loiodice, P Tortorella, ...
Foods 10 (1), 29, 2020
372020
Importance of biometals as targets in medicinal chemistry: An overview about the role of Zinc (II) chelating agents
R Leuci, L Brunetti, A Laghezza, F Loiodice, P Tortorella, L Piemontese
Applied Sciences 10 (12), 4118, 2020
292020
Structure-based design of novel donepezil-like hybrids for a multi-target approach to the therapy of Alzheimer's disease
L Brunetti, R Leuci, A Carrieri, M Catto, S Occhineri, G Vinci, ...
European Journal of Medicinal Chemistry 237, 114358, 2022
202022
Food industry byproducts as starting material for innovative, green feed formulation: a sustainable alternative for poultry feeding
L Brunetti, R Leuci, MA Colonna, R Carrieri, FE Celentano, G Bozzo, ...
Molecules 27 (15), 4735, 2022
172022
Novel phenothiazine/donepezil-like hybrids endowed with antioxidant activity for a multi-target approach to the therapy of Alzheimer’s disease
A Carocci, A Barbarossa, R Leuci, A Carrieri, L Brunetti, A Laghezza, ...
Antioxidants 11 (9), 1631, 2022
102022
A new series of aryloxyacetic acids endowed with multi-target activity towards peroxisome proliferator-activated receptors (PPARs), fatty acid amide hydrolase (FAAH), and …
R Leuci, L Brunetti, A Laghezza, L Piemontese, A Carrieri, L Pisani, ...
Molecules 27 (3), 958, 2022
102022
A chemoinformatics search for peroxisome proliferator-activated receptors ligands revealed a new pan-agonist able to reduce lipid accumulation and improve insulin sensitivity
S Sblano, C Cerchia, A Laghezza, L Piemontese, L Brunetti, R Leuci, ...
European Journal of Medicinal Chemistry 235, 114240, 2022
72022
Can foods influence the onset and progress of neurodegenerative diseases?
L Piemontese, L Brunetti, R Leuci
Neural Regeneration Research 17 (11), 2443-2444, 2022
52022
A Review of Recent Patents (2016-2019) on Plant Food Supplements with Potential Application in the Treatment of Neurodegenerative and Metabolic Disorders
R Leuci, L Brunetti, A Laghezza, P Tortorella, F Loiodice, L Piemontese
Recent patents on food, nutrition & agriculture 11 (2), 145-153, 2020
22020
A New Antidiabetic Agent Showing Short-and Long-Term Effects Due to Peroxisome Proliferator-Activated Receptor Alpha/Gamma Dual Agonism and Mitochondrial Pyruvate Carrier …
A Laghezza, C Cerchia, M Genovese, R Leuci, E Pranzini, A Santi, ...
Journal of Medicinal Chemistry 66 (5), 3566-3587, 2023
12023
Role of copper chelating agents: between old applications and new perspectives in neuroscience
R Leuci, L Brunetti, V Tufarelli, M Cerini, M Paparella, N Puvača, ...
Neural Regeneration Research 20 (3), 751-762, 2025
2025
A Chemical Modification of a Peroxisome Proliferator-Activated Receptor Pan Agonist Produced a Shift to a New Dual Alpha/Gamma Partial Agonist Endowed with Mitochondrial …
A Laghezza, C Cerchia, M Genovese, R Montanari, D Capelli, J Wackerlig, ...
European Journal of Medicinal Chemistry, 116567, 2024
2024
Green Methods to Recover Bioactive Compounds from Food Industry Waste: A Sustainable Practice from the Perspective of the Circular Economy
V Roselli, G Pugliese, R Leuci, L Brunetti, L Gambacorta, V Tufarelli, ...
Molecules 29 (11), 2682, 2024
2024
A NEW ANTIDIABETIC AGENT SHOWING PPARα/γ DUAL AGONISM AND MITOCHONDRIAL PYRUVATE CARRIER INHIBITION
C Cerchia, A Laghezza, M Genovese, R Leuci, E Pranzini, A Santi, ...
Book of Abstracts, 63-63, 2023
2023
IDENTIFICATION OF A NOVEL PPARRα/γ DUAL AGONIST SHOWING ANTIDIABETIC EFFECTS AND ABLE TO BIND TO CANONICAL AND ALLOSTERIC SITES OF ABLE TO BIND TO CANONICAL AND ALLOSTERIC …
A Laghezza, L Brunetti, R Leuci, P Tortorella, L Piemontese, P Paoli, ...
Book of abstracts, 119-119, 2023
2023
Rivastigmine-based hybrids: a multi-target approach to anti-Alzheimer’s drug design
R Leuci, S Simic, L Brunetti, G LA SPADA, P Tortorella, F Loiodice, ...
Proceedings of Chimica sotto l’albero–innovazione e resilienza: giovani …, 2023
2023
New rivastigmine-like compounds for the potential treatment of Alzheimer’s disease: a multi-target approach
R Leuci, S Simic, L Brunetti, G LA SPADA, P Tortorella, F Loiodice, ...
Proceedings of the Merck Young Chemists’ Symposium XXII edition, 31-31, 2023
2023
含有生物活性小分子食品或可延缓神行退行性疾病的发展
L Piemontese, L Brunetti, R Leuci
中国神经再生研究 (英文版) 17 (11), 2443, 2022
2022
Novel rivastigmine structure-based hybrids for the potential treatment of Alzheimer’s disease
R Leuci, L Brunetti, A Carrieri, M Catto, A Laghezza, P Tortorella, ...
Book of Abstracts XXVII NMMC-NPCF 14, 144-144, 2022
2022
Nature-inspired structures for the multi-target treatment of Alzheimer’s disease: a successful approach for drug design
R Leuci, V Poliseno, M Solfrizzo, SM Amélia, C Sílvia, A Laghezza, ...
Book of Abstracts ICEMAP2022, 21-21, 2022
2022
系统目前无法执行此操作,请稍后再试。
文章 1–20